The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Lloyd-smith Malcolm since year 2005.
The trader's CIK number is 1557146.
At the time of this reporting, Lloyd-smith Malcolm is the Chief Regulatory Officer of Neurocrine Biosciences Inc .
(stock ticker symbol NBIX).
See this page for all insider trading activities at Neurocrine Biosciences Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-05-18||NBIX||Neurocrine Biosciences Inc||Option Ex||4,980||15.45||76,941|
|2017-05-19||NBIX||Neurocrine Biosciences Inc||Option Ex||4,980||15.45||76,941|
|2017-05-18||NBIX||Neurocrine Biosciences Inc||Sale||4,980||53.26||265,234|
|2017-05-19||NBIX||Neurocrine Biosciences Inc||Sale||4,980||54.00||268,920|
|2017-04-12||NBIX||Neurocrine Biosciences Inc||Sale||13,065||50.82||663,963|
|2017-02-06||NBIX||Neurocrine Biosciences Inc||Sale||727||43.15||31,370|
|2017-02-07||NBIX||Neurocrine Biosciences Inc||Sale||116||44.61||5,174|
|2016-09-01||NBIX||Neurocrine Biosciences Inc||Option Ex||9,000||15.45||139,050|
|2016-09-01||NBIX||Neurocrine Biosciences Inc||Sale||9,000||50.00||450,000|
|2013-07-22||CADX||Cadence Pharmaceuticals Inc||Option Ex||14,000||3.51||49,140|
|2013-07-22||CADX||Cadence Pharmaceuticals Inc||Sale||14,000||7.85||109,900|
|2013-06-10||CADX||Cadence Pharmaceuticals Inc||Sale||4,000||7.44||29,760|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lloyd-smith Malcolm (Chief Regulatory Officer of Neurocrine Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.